CNSY — CERENOME, INC. catalysts
Next verified catalyst
2026-10-02 — Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeninge · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-02 in 12d
ESTIMATED |
READOUT
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Le
Phase 1/2 · Leptomeningeal Metastasis |
CNSY CERENOME, INC. | 186RNL |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|